Skip to main content
. 2021 May 28;6:36. doi: 10.1038/s41525-021-00198-5

Table 1.

Summary of genetic mutations described in telomere biology disorders.

Gene mutation Product Inheritance Disease and phenotype Frequency Comment
TERT57,17,47,50,54,59 TERT

Autosomal dominant

Autosomal recessive

DCa

IPFb/FIPc

AAd/MDSe

Familial Liver Cirrhosis

DC

HHSf

15–25%

8–15% (familial)

1–3% (sporadic)

3–5% (AA)

20% (familial MDS-AMLi)

Rare, unknown

Rare

TERT and TERC mutations are the most common TBD mutations and present later in life.
TERC5,6,20,47,50,54,59

Telomerase RNA

component

Autosomal dominant

DC

IPF/FIP

AA/MDS

Familial Liver Cirrhosis

10%

8–15% (familial)

1–3% (sporadic)

3–5% (AA)

20% (familial MDS-AML)

rare, unknown

TERT and TERC mutations are the most common TBD mutations and present later in life.
DKC110,48 Dyskerin X-linked recessive

DC

HHS

IPF/FIP

15–25%

rare

<1%

Described in severe X-linked DC, which presents in the first decade of life
RTEL119,29,50 RTEL1

Autosomal recessive

Autosomal dominant

DC

HHS

IPF/FIP

Rare

Rare

5–10%

TINF216,49 TIN2 Autosomal dominant

DC

HHS

RSg

IPF/FIP

Rare

Rare

Rare

<1%

Results in very short telomeres. Presentation ranges from milder disease (e.g., FIP) to early-onset severe diseases (e.g., HHS, DC). Only mutation identified with RS
PARN11,29 PARN

Autosomal dominant

Autosomal recessive

IPF/FIP

DC

HHS

5%

Rare

Rare

Biallelic and monoallelic variants are associated with DC, HHS, and IPF, respectively
ZCCHC828 ZCCHC8 Autosomal dominant FIP Rare
NAF1 NAF1 Autosomal dominant IPF/FIP, CPFEh <1%

NOP1013

NHP218

WRAP5332

CTC112,35

NOP10

NHP2

TCAB1

CTC1

Autosomal recessive DC Rare CTC1 has been described in Coats’ plus
ACD14 TPP1

Autosomal dominant

Autosomal recessive

AA

DC

HHA

Rare

Rare

References are in numerical superscript.

aDyskeratosis congenita.

bIdiopathic pulmonary fibrosis.

cFamilial interstitial pneumonia.

dAplastic anaemia.

eMyelodysplastic syndrome.

fHoyeraal–Hreidarsson syndrome.

gRevesz syndrome.

hCombined pulmonary fibrosis and emphysema.

iAcute myeloid leukaemia-myelodysplastic syndrome.